NR3C2 and Cushing syndrome: Nevertheless, the marked beneficial action of MR antagonism demonstrated in the treatment of cardiac failure, often in the absence of elevated aldosterone or sodium retention, strongly suggests that a similar therapeutic approach would be worth of investigation in the context of different pathophysiological situations, including cardiomyopathies associated with diabetes mellitus, Cushing syndrome, or reperfusion after ischemia.